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ABSTRACT  
The purpose of this study was to examine if anxiety diagnoses were associated 
with increased risk for suicidality and to examine if comorbid anxiety and depression 
diagnoses have a synergistic effect on suicidality. In a sub-analysis, we assessed 
associations between anxiety and/or depression symptoms (versus diagnoses) with 
suicidality in order to inform a future study.  
Completed at the Burlingame Center for Psychiatric Research and Education at 
the Institute of Living (IOL) in Hartford, CT, this quantitative, cross-sectional study 
involved 20,823 adult inpatients admitted for psychiatric care from 2000-2009. Estimates 
of effects calculated were odds ratios (ORs) qualified at 95% confidence intervals (CIs). 
Descriptive, bivariate, and stratified statistics were utilized in the study. Through analysis 
of two-way interactions, we judged evidence of synergism or antagonism. Finally, we 
constructed binary logistic regression models to assess the anxiety - suicidality 
association.  
We found that anxiety and depression diagnoses were associated with 
approximately 40% and 160% increased risk of suicidality after controlling for 
demographic and clinical confounders. Furthermore, our analysis provided evidence that 
the effects on risk of suicidality of these two diagnostic groups were independent, neither 
synergistic nor antagonistic in this population. Preliminary analyses suggest that anxiety 
symptom information may be a better predictor of suicidality than the presence of a 
DSM-IV diagnosis. Additional research is warranted to examine the nature of anxiety 
symptoms that precede suicidal behaviors and to examine if symptom clusters work 
synergistically to increase suicidal risk as well as what symptom clusters present the 
greatest suicidal risk. 
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CHAPTER I 
INTRODUCTION 
Scope of the Problem 
Suicidality is a global concern. In fact, on September 10, 2009, during the World 
Suicide Prevention Day, Mishara stated: 
We live in a world where the media bombards us daily with stories of violent deaths 
occurring in the context of wars, terrorist attacks and homicides. Yet, worldwide each 
year, more human beings kill themselves than are killed in all wars, terrorist attacks 
and homicides combined. (p. 1) 
 
The World Health Organization (2008) estimates that every 40 seconds someone in the world 
dies by suicide, which adds up to 1 million suicides across the world each year. The National 
Institute of Mental Health (NIMH) (2009), using data from the Center for Disease Control 
(CDC), reported that in 2006 suicide was the eleventh leading cause of death in the United 
States. In that year, the incidence of suicide was 10.9 per every 100,000 people, amounting to 
33,000 deaths in the US alone.  
Table 1. Number of Suicides by Age in the United States in 2006  
(Adapted from Heron et al., 2009.) 
 
Population by age in years Number of deaths by Suicide 
  5-14    219 
15-24 4,189 
25-34 4,985 
35-44 6,591 
45-54 7,426 
55-64 4,583 
65-74 2,384 
75-84 2,075 
85 and over    840 
Not stated        8 
Total 33,000 
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Astoundingly, for every suicide death the NIMH (2009) estimates that there are 12-25 
nonfatal suicide attempts, accounting for as many as 825,000 attempts per year in the U.S., a 
rate of approximately one for every 37 citizens. When you factor in the number of attempts 
and the number of people plagued by suicidal ideation, the toll in human suffering is 
immeasurable. The problem has become of such importance that suicide prevention has been 
identified as a national and world imperative by the Institute of Medicine National 
Academies (Goldsmith, Pellmar, Kleinman, & Bunney, 2002), the U.S. Surgeon General 
(U.S. Public Health Service, 1999), and the World Health Organization (2008).  
Predicting Suicidality 
The relationship between psychiatric illness and suicidality has been discussed 
frequently in the psychosocial literature. (Suicidality is defined herein as the range of suicidal 
behaviors including ideation, attempts, and completed suicide.) In fact, diagnoses and 
incidence of suicidality have been studied in the past to determine if certain psychiatric 
diagnoses carry a higher risk for suicidal behaviors (Bernal et al., 2007; Nock et al., 2008), 
and some differences have been noted. However, despite the plethora of research available, 
much is still unclear about the exact components of mental illness that lead to suicidality. The 
fact that, compared to the risk of suicidality in the general population, the risk is elevated 
across individuals with psychiatric diagnoses suggests that a common element or elements in 
individuals with these diagnoses may be the root cause(s) of suicidality among mental health 
patients. Psychiatric disorders often share the same symptom(s) in their diagnostic profiles, 
although the prevalence of these symptoms may vary by diagnosis. Thus if a symptom or 
symptoms and not diagnoses are causative for suicidality, the variation in prevalence of 
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symptoms may explain why the risk for suicidal behaviors differs between psychiatric 
diagnoses. Isolating the exact components that are predictive of suicidal behavior is 
important for accurate assessment (in terms of sensitivity and specificity for the prediction of 
suicidality) and treatment. For example, because suicide attempts can occur in the absence of 
mental illness and can occur across a variety of diagnoses, suicidal risk cannot be based on 
current definitions of diagnoses alone. Although postmortem studies have indicated that 90% 
of all people who commit suicide have a psychiatric disorder (Yan, 2009),  the World Health 
Organization (WHO) found that mental illness was prevalent in only 65.7% of suicide 
attempters in developed countries and 54.6% in developing countries (Nock et al., 2009). 
Furthermore, when looking at the diagnosis of depression, Yan (2009) underscored that in 
the multi-national study conducted by WHO, researchers found that although depression was 
strongly associated with suicidal ideation, it was not predictive of suicide attempts. This is a 
strong departure from conventional wisdom and the findings of many studies, and raises 
questions about the assumed necessary role of depression in the progression of suicidality 
(Nock et al., 2009).
 
In fact, the WHO found that the only commonalities across diagnoses in 
both developed and developing countries that were predictive of the transition from suicidal 
ideation to suicidal attempts were anxiety symptoms and impulsivity (Nock et al., 2009).  
An argument could be made for reformulating diagnostic criteria and taxonomy to 
better differentiate and screen disorders that also present with symptoms of anxiety and/or 
impulsivity. In light of the importance of comorbid mood disorders and anxiety, an affect 
disorder workgroup from the American Psychiatric Association is even debating whether to 
add a new diagnostic category called “Anxious Depression or Mixed Anxiety-Depression” 
(Fawcett, 2009) for the Diagnostic and Statistical Manual of Mental Disorders, 5
th
 edition 
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(DSM-V) that will be published in 2012. The workgroup is also discussing whether to add a 
dimensional aspect to mood disorders in general that would assess severity across various 
symptom variables and/or whether anxious depression should be listed as a separate 
diagnosis. However, an important consideration is that symptoms of anxiety that do not meet 
the full criteria to warrant an anxiety diagnosis still may have important implications in 
suicidal assessment, particularly in patients with depression (Diefenbach, Woolley, & 
Goethe, 2009). Furthermore, although a change in diagnostics may help inform clinical 
practice and treatment plan development, the changes in diagnoses alone may not be the most 
effective way to promote understanding of the development and prediction of suicidality.  
Suicide has been associated with multiple environmental/social and psychological 
causal pathways. Environmental/social triggers include major life events such as loss of 
loved ones, social isolation and employment problems. In the psychological arena, early 
psychoanalytic theory proposed that suicide is aggression or hatred turned inward against 
one’s self (Gonda, Fountoulakis, Kaprinis, & Rihmer, 2007; Joiner, 2005). Multiple other 
psychological theories have been developed since then including theories about hopelessness 
(Gonda et al., 2007) or about what Shneidman termed “psychache” or “psychological pain” 
being the root of suicidality (Joiner, 2005). More recent theories include Linehan’s 
biopsychosocial model that indicates that a biological predisposition, an oversensitive 
temperament, an invalidating environment and/or trauma work to contribute to an inability to 
regulate emotions (Joiner, 2005). This emotional dysregulation can result in self-injury or 
suicidal behaviors.  
Although affective, anxiety, and impulse control disorders have each been 
investigated independently as predictors of suicidality, formal research is needed to consider 
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potential synergistic effects of the disorders. To address this issues, the study described 
herein considered the elements of the development of suicidality suggested in the literature 
described above by examining the crude associations of anxiety and of depression, (as 
diagnoses), independently and in combination with suicidality in a population of adult 
psychiatric patients treated in a community hospital. Ultimately, the purpose of this study 
was to explore in depth the mechanisms underlying suicidal ideation and suicide attempts by 
examining the joint effect of anxiety and depression in order to enhance risk assessment. 
Obviously, the relevance of the study to clinical practice is the impact that it will have on 
assessment of suicidality, treatment, and follow-up care.  
 
Relevance to Social Work 
The relevance of this research to social work is that it may support better outcomes 
for suicidal people by providing information that can inform screening protocols for 
suicidality and by informing therapeutic interventions. For example, if depression with co-
occurring anxiety causes an increase in suicidality that exceeds the sum of the individual 
effects of these other two conditions, therapeutic techniques and medications can be 
structured aggressively around targeted symptom combinations to reduce their effects. Also, 
being able to predict if patients are at an elevated risk of suicidality can help determine the 
level of care appropriate to ensure patient safety and to determine the type of safety plans that 
are needed. Understanding the mechanisms behind suicidal behaviors in advance of 
completed suicides will provide information that may provide clarity about effective steps in 
improving outcomes of treatment by stopping suicidal ideation and attempts from escalating 
to completed suicides. Thus, by utilizing evidence-based research in treatment not only is 
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patient care improved, but the professional credibility of social workers is enhanced. More 
importantly, working on reducing human suffering and improving quality of life, which in 
turn promotes social justice, is in keeping with the National Association of Social Worker’s 
Code of Ethics (2008). 
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CHAPTER II 
LITERATURE REVIEW 
Previous authors have noted that identifying and determining how certain factors 
synergistically foster suicidal behaviors and the process that leads from suicidal ideation to 
completed suicide is complex and still unknown. For example, Goldsmith, Pellmar, 
Kleinman, and Bunney (2002) reported: 
Despite the extensive knowledge that research has provided regarding these 
[suicidal] risk and protective factors, we are still far from being able to 
integrate these factors so as to understand how they work in concert to evoke 
suicidal behavior or to prevent it. (p. 3) 
A review of previous research shows that the relationship of suicidality with anxiety 
disorders is confusing in part because of the many forms of these disorders including 
posttraumatic stress disorder (PTSD), panic disorder (PD), and generalized anxiety disorder 
(GAD). Researchers, at present, do not agree on the form(s) of anxiety disorder that is/are 
most associated with suicidality.  
For example, Diaconu and Turecki (2007) conducted a cross-sectional study 
exploring panic disorder, major depressive disorder, and suicidality among 474 outpatient 
psychiatric subjects. The authors concluded that panic disorder was associated only with 
suicidal behavior if the patient had comorbid depression. By comparing suicidal behavior 
across three groups consisting of a panic disorder with comorbid depression group, a 
depressive disorders group, and a panic disorders alone group, Diaconu and Turecki 
concluded that the increase in suicidality was attributed to comorbid depressive disorder. 
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Because there was little difference in terms of increased risk for suicidal behavior between 
both the depressive disorders group and the panic disorder with comorbid depression group, 
they concluded that underlying depressive disorder was the critical indicator for suicidal 
behaviors. The weakness in this study was a relatively small sample size (78) of patients with 
panic disorder. A further limit to the study was its inability in allowing the researchers to 
evaluate a participant’s suicidality during an active panic attack or across time. Depending on 
which comorbid disorders were controlled for, other studies resulted in different conclusions 
about the relationship between panic disorder and suicidality (Vickers & McNally, 2004; 
Nock et al., 2009; Beautrais et al., 1996).  
Diaconu and Turecki’s (2007) evidence that underlying depression and not panic 
disorder is the key indicator for suicidality, contrasts dramatically with the recent World 
Health Organization’s (Nock et al., 2009) cross-national analysis which involved a much 
larger sample size. In various nations, the presence (versus absence) of panic disorder was an 
independent, significant predictor of suicide attempts (ORs = 2.3-3.0) (not just suicidal 
ideation), after rigorously controlling for various comorbid disorders. 
The analysis of the National Comorbidity Survey replication (NCS-R) by Cougle, 
Keough, Riccardi, and Sachs-Ericsson (2009) had yet different findings that indicated panic 
disorder was only significantly associated with suicidal ideation and not predictive for 
suicide attempts. In addition, in this study, findings suggested that anxiety disorders in 
general, independent of depression and other psychiatric conditions, were significantly 
correlated with suicidal behavior. This two-step study evaluated English-speaking 
participants from the contiguous United States, and in the first interview identified those 
individuals who met the criteria of having a lifetime diagnosis of anxiety disorder and a 
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comparison group that was representative of those without a diagnosis of anxiety disorder. 
This subsample included 4,131 participants who completed the second interview providing 
information regarding lifetime suicidal ideation and suicide attempts. Specifically, after 
controlling for other psychiatric conditions and demographic variables, the study found that 
the presence (versus absence) of social anxiety disorder (SAD), posttraumatic stress disorder 
(PTSD), generalized anxiety disorders (GAD), as well as panic disorder (PD) predicted 
suicidal ideation, whereas among these anxiety disorders only the presence of SAD, PTSD, 
and GAD predicted suicide attempts (Cougle et al., 2009). A hypothesis based on the 
investigators’ findings is that anxiety may cause severe distress in patients, especially if the 
anxiety is severe, so that assessing for suicidality is warranted when patients appear to be 
severely anxious. 
In contrast to Cougle et al.’s (2009) findings, Sareen, Houlahan, Cox, and 
Asmundson (2009), examining a large nationally representative sample of 5,877 participants 
ranging in age from 15-54 years (82.4% response rate), found PTSD to be the only anxiety 
disorder statistically significantly associated with suicidal ideation and attempts. Other 
anxiety disorders examined included lifetime social phobia, PD, agoraphobia, and GAD. 
Using multivariate analyses controlling for demographics, PTSD was associated with a 
nearly three-fold increased risk of ideation and of attempts. The validity of these results is 
supported by the study’s use of a scale to establish diagnoses (the Composite International 
Diagnostic Interview). 
Interpreting the research results about anxiety’s role in suicidality discussed above, in 
light of additional study findings, suggests that symptoms of anxiety are likely to be critical 
factors in suicidality even in the absence of a specific anxiety diagnosis. Support for this 
10 
 
thesis was found in a study conducted by Diefenback, Woolley, and Goethe (2009) at a major 
psychiatric facility. A cross-sectional analysis examined 2,778 outpatients’ psychiatric 
diagnoses established by unstructured clinical interviews. Outpatients also self-reported on 
their symptoms including difficulties with anxiety (defined here as experiencing fear, anxiety 
or panic) and with suicidal thoughts and behaviors on a standardized self-report questionnaire 
completed upon admission. Presence (versus absence) of anxiety symptoms was associated 
with a two-fold increase in the likelihood of suicidality, after controlling for potential 
confounding by anxiety disorders, depressive disorders, symptoms of depression, and 
demographics. However, this study may be limited because the psychiatric interviews 
establishing diagnoses were unstructured and generalizability to other clinic populations 
might have been limited because the sample consisted only of people receiving outpatient 
care. 
Previous research, including the studies discussed above, considered as a whole 
strongly suggests an independent role of anxiety disorders (and perhaps of anxiety symptoms 
alone) in the development of suicidality, although the studies contain methodological 
limitations including the approaches to measuring psychiatric conditions, cross-sectional 
study designs, and sampling that may have affected the generalizability of findings. For 
example, Bongiovi-Garcia et al. (2009) conducted a study assessing how the use of 
unstructured psychiatric interviews could impact the accuracy of the assessment of patient 
suicidal ideation. In this study, postgraduate year II physicians (PGYII) supervised by an 
attending psychiatrist completed unstructured assessments of 201 adult inpatients diagnosed 
with either major depressive disorder or bipolar disorder (based on the DSM III-R, 1987, 
third edition revised), and the results were compared to assessments by structured interviews 
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conducted by master’s or Ph.D. level clinicians. Bongiovi-Garcia et al. found that 29.7% of 
patients identified by a structured interview as having suicidal ideation were not diagnosed 
accurately by the PGYIIs. A potential bias in the study, however, was that clinicians 
administering both structured and unstructured interviews were not blind to the purposes of 
the study. Despite this limitation the study demonstrates how suicidal ideation may be 
underrepresented in clinical diagnosis, which represent the diagnoses in the majority of 
studies on psychiatric diagnoses and suicidality.  
Bongiovi-Garcia et al.’s (2009) study demonstrates one way that methodology can 
influence the results of a study. As is often a limitation throughout psychiatric research, 
designing a study to measure the actual state of mind of the patient, i.e., the true nature and 
severity of psychiatric morbidity, is the most obvious challenge, and it is also difficult to 
identify the events or circumstances leading to suicidal behaviors. However, this problem can 
be lessened in research directed toward identifying predictors instead of the causal 
mechanism for suicidality. In this sense, if what a patient reports, true or false, helps predict 
suicidality, it is clinically useful. Similarly, if an unstructured approach to establish diagnoses 
is used, and the diagnoses thus replicate those likely available in clinical settings, such 
diagnoses could be useful predictors of suicidality. In this way, the true challenge of research 
is to identify the information that most specifically predicts suicidality.  
In an interview with Yan (2009), Nock noted that that future studies are being 
proposed to examine “symptom clusters” because approximately 52% of the people who had  
considered suicide seriously (which referred to ideation and not attempts in this study) in 
developed countries and 43% in undeveloped countries, did not report a prior lifetime DSM-
IV diagnosis (Nock et al., 2009). This new focus on symptoms alone requires researchers not 
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only to identify symptoms that are associated with suicidality, but to consider carefully the 
potential usefulness of sets of factors not necessarily individually associated with suicidality 
in future studies. 
Additionally, many previous studies were cross-sectional studies and often involve a 
retrospective self-report of lifetime occurrences of events, emotions and feelings. 
Retrospective self-reports are susceptible to recall bias, particularly as this type of psychiatric 
research requires that patients self-report about personal, traumatic, and unpleasant events. 
However, because many traumas are major life events, recall bias may be less of a limitation 
when patients are asked yes/no questions. Nonetheless, establishing the chronology of events 
is a necessary factor to support associations as either suggesting cause or as useful for 
prediction to support interventions. Remembering the sequence of major events in one’s life, 
unless they were perceived to be related, is likely to have biased some past studies. 
The study described herein differs from prior research in a variety of ways. The study 
enables a cross-sectional analysis of the synergistic effects of anxiety and depression 
diagnoses on the risk of suicidality after controlling for other diagnoses, 
psychopharmacology treatment, and demographics. Examining anxiety and depressive 
diagnoses together will advance the literature by estimating anxiety diagnoses’ value in 
predicting suicidality, independent of the effects of a depression diagnosis and controlling for 
other potential risk factors. In addition, this study serves to inform an upcoming longitudinal 
research project that will examine the associations between diagnoses, symptoms, and 
perhaps symptom clusters with subsequent suicidality. The premise we are exploring is that 
co-occurring anxiety and depressive symptoms versus comorbid anxiety and depression 
diagnoses will be more predictive of suicidality. Furthermore, interviews with patients during 
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the upcoming project will allow for comprehensive examination of symptoms and clusters of 
symptoms. In this way, the current thesis informs the design of the second study by providing 
an in-depth examination of the anxiety-suicidality association. Such an examination may be 
useful in planning clinical intervention. Although there have been multiple studies on 
suicidal behavior, accurately predicting patient risk for suicidal behaviors is still difficult. 
Demonstrating the need for continued research the WHO (Nock et al., 2009), after 
conducting a multinational study involving 108,664 participants from 21 countries, recently 
remarked, “A crucial goal for future research is to better understand how and why such a 
diverse range of disorders are uniquely associated with suicide attempts” (p.13).  
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CHAPTER III 
METHODOLOGY 
Research 
The question we are examining is if an anxiety diagnosis is in fact predictive of 
suicidality in an adult psychiatric inpatient population. If anxiety is predictive of suicidality, 
does comorbidity with depression have a synergistic effect causing an even greater risk for 
suicidality than the additive risks of having depression symptoms alone or anxiety symptoms 
alone? The hypotheses, tested in a cross-sectional sample of psychiatric adult inpatients, 
included the following:  
1. Presence of an anxiety diagnosis (any) will be statistically significantly 
associated with suicidality (either suicide ideation or attempts), after 
controlling for confounding by demographics. 
2. Additionally controlling analytically for the presence of other psychiatric 
diagnoses will not explain the expected association between anxiety diagnosis 
and suicidality.  
3. The presence of both an anxiety disorder and a depressive disorder will have a 
synergistic effect on the risk of suicidality, as demonstrated by an increase in 
risk of suicidality among patients with both an anxiety diagnosis and a 
depression diagnosis compared to patients with neither diagnosis being greater 
than the sum of the increases of risk for patients with an anxiety diagnosis 
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alone and patients with a depression diagnosis alone, each compared to 
patients without either diagnosis.  
Additional research questions that were examined but not formally statistically tested 
included the following, 
4. Crude analysis will suggest that anxiety symptoms are statistically 
significantly associated with suicidality (either suicide ideation or attempts).  
5. Crude analysis will suggest that depressive symptoms are statistically 
significantly associated with suicidality (either suicide ideation or attempts). 
6. Crude analysis will suggest that the relative risk of suicidality for anxiety 
symptoms (presence versus absence) will be greater than the relative risk of 
suicidality for a diagnosis of an anxiety disorder (any – yes/no).  
7. Crude analysis will suggest that the relative risk of suicidality for depressive 
symptoms (presence versus absence) will be greater than the relative risk of 
suicidality for a diagnosis of a unipolar affective disorder (any – yes/no). 
These crude analyses will inform the design of a subsequent, longitudinal 
study. 
8. In an examination of two-way interactions, the presence of both anxiety 
symptoms and depressive symptoms will have a synergistic effect on the risk 
of suicidality, as demonstrated by an increase in risk of suicidality among 
patients with both anxiety symptoms and depression symptoms compared to 
patients with no symptoms being greater than the sum of the increases of risk 
for patients with anxiety symptoms alone and patients with depression 
symptoms alone, each compared to patients without any symptoms.  
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Research Methods 
This study was completed in collaboration with, and advice from, Dr. Stephen 
Woolley, Senior Scientist at the Burlingame Center for Psychiatric Research and Education 
at the Institute of Living (IOL) in Hartford, CT, who also served as thesis advisor. The study 
was a quantitative, cross-sectional study drawing analytic goals from previous studies at the 
IOL. The study was completed under the previous Hartford Hospital protocol (HH #2118) 
and examined data routinely collected at the IOL. This cross-sectional analysis examined the 
association between anxiety and suicidality after controlling for diagnoses, 
psychopharmacology treatment and demographics. The Institute of Living/Hartford 
Hospital’s Institutional Review Board (IRB) (protocol HH #2118 as referenced above) 
previously approved the research conducted for the purposes of this thesis in compliance 
with hospital and Federal research regulations for the protection of human subjects. 
 
Sampling and Recruitment 
Study subjects were drawn from the target population of adult (defined as greater than 
or equal to 18 years of age) psychiatric inpatients admitted for care during the 10-year period 
from January 2000-March 2009 at the IOL. This time period was selected in order to ensure 
adequate statistical power but to avoid possible changes in diagnostic practice that might 
occur over a longer time period. Participants were recruited using the IOL’s on-going 
database of all admitted inpatients. The cross-sectional study sample consisted of 20,823 
adults for whom data were collected upon admission to the IOL by the hospital’s Outcome 
Assessment Program (OAP). In addition to the cross-sectional analysis, a substudy of 
patients who completed OAP follow-up post-discharge questionnaires during the final five 
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years of the ten-year period was examined to assess patients over time. The subsample 
included all 948 adult patients who voluntarily completed OAP questionnaires at 1 month 
follow-up and all 202 patients who voluntarily completed OAP questionnaires at 6 month 
follow-up. At no point did the research restrict or impact receiving appropriate mental health 
care as the IRB assured that the continuity and unfettered delivery of patient care and 
confidentiality was maintained.  
 
Data Collection 
The IOL routinely administers these self-reported OAP questionnaires upon hospital 
admission. Post-discharge, the IOL then mails OAP questionnaires to all previous inpatients 
at 1 month and 6 month follow-up. In addition, data recorded in the hospital’s clinical 
database included inpatient diagnoses, demographics (such as age, race, sex, and ethnicity), 
and psychopharmacologic agents utilized in treatment. Symptom information recorded from 
post-discharge returned OAP responses and entered into the OAP database included anxiety 
and depression symptoms. The OAP questionnaires, developed by Dr. John Goethe at the 
IOL, which include symptom questions (see Appendix B) adapted from the McLean Hospital 
Basis-32 (Eisen, Grob, & Klein, 1989), is used in evaluating treatment 
outcome/improvement.  
The two primary independent variables included diagnoses of anxiety and of 
depression. A diagnosis of anxiety consisted of PTSD, SAD, GAD, obsessive-compulsive 
disorder (OCD), and/or PD. A diagnosis of depression consisted of having any of the 
following disorders: major depressive disorder, mood disorder not otherwise specified, 
dysthymic disorder, or depressive disorder not otherwise specified. Bipolar disorder and its 
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variants were excluded from the study because mixed and manic states, which can involve 
symptoms relating to both depression and anxiety, would have rendered results 
uninterpretable. Anxiety symptoms were defined as having fear, anxiety, or panic with a 
response of “none” or “little” representing the absence of symptoms and “moderate,” “quite 
a bit,” or “extreme” representing the presences of symptoms. Similarly, the presence versus 
absence of depressive symptoms was rated on the same dichotomous scale.  
During the study, factors targeted for control analytically included age, race, sex, 
ethnicity, psychopharmalogical agents, other mental illness diagnoses, and personal difficulty 
in the previous month with problems or areas of daily life (e.g., managing day-to-day, 
relationship with family, self-confidence, disturbing thoughts). These covariates were 
assessed for possible confounding of the analysis of risk of suicidality associated with 
anxiety or depression diagnoses. We collapsed categories of responses about difficulties to 
compare patients having “none,” “little,” or “moderate” difficulty with those having “quite a 
bit” or “extreme” difficulty. In addition, we examined these variables dichotomized with 
other cut-points. 
The dependent variable for all analyses was suicidality coded dichotomously by 
collapsing categories of responses to a question asking about difficulty in their every day 
lives during the past month with “suicidal feelings or behavior (thinking about or attempting 
suicide by any means).” Absence of suicidality was indicated if patients indicated that they 
had “none” or “little” difficulty, and presence of suicidality if they had “moderate,” “quite a 
bit,” or “extreme” difficulty.  
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Data Analysis 
The following analytical approach was based on approaches utilized in the 
Burlingame Center (Woolley, Fredman, Goethe, Lincoln, & Heeren, 2008; Diefenbach, 
Woolley, & Goethe, 2009) and executed under the direction of Dr. Woolley. Descriptive 
statistics were utilized to examine the properties of the population with implications for 
generalizability. Bivariate analyses were examined to further describe the study population, 
to assess the crude hypothesized associations, and to investigate the crude associations 
between potential confounders (identified in the literature or selected by the authors based on 
theories of the progression of suicidality) that might affect the results of hypothesis testing. 
Estimates of effects calculated in all analyses were odds ratios (ORs), and indications of the 
precision of these estimates were expressed as 95% confidence intervals (CIs) calculated by 
the approximate method. For these and stratified analyses, variables were dichotomous.  
In addition, we examined the significance of pairwise associations of variables using 
t-tests, one-way analysis of variance (ANOVA) or Pearson correlation coefficients to assess 
associations involving continuous measures, and chi-square analysis for paired dichotomous 
variables. Following bivariate analysis, we stratified the analysis of the associations between 
primary exposures and outcomes by strata of covariates that appeared to be associated with 
these exposures and outcomes. These analyses allowed us to estimate the adjusted ORs while 
controlling for confounding by individual covariates. The ORs were estimated by calculating 
the Mantel-Haenszel pooled estimator of the ORs (Rothman & Greenland, 1998). Stratified 
analysis also allowed us to examine for modification of the effects of exposures on outcomes, 
and to characterize the effect on risk of suicidality of dual exposures to anxiety or depression 
and a covariate. In this way, we assessed interaction reflecting possible synergy or 
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antagonism of primary exposures with additional patient characteristics. We judged evidence 
of synergism or antagonism by applying the criteria that deviations of the combined effects 
from additivity of the individual effects were  25% among the doubly exposed. Finally, we 
constructed binary logistic regression models of the risk of suicidality by controlling for 
demographics and other identified potential confounders, and selecting additional covariates 
using a stepwise selection algorithm (p = 0.10 inclusion/removal criterion). 
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CHAPTER IV 
RESULTS  
Univariate/Descriptive Analyses  
From univariate analysis, it was determined that the population consisted of 10,767 
females and 10,056 males for a total target population of 20,823 patients. The mean age was 
43.0 years of age with patients ranging from age 18 to 102. Race was collapsed into a 
dichotomous variable with 13,020 patients who identified as White and 7,803 who identified 
as Black, Asian, Native American Indian, Hispanic, or Other, all of whom we categorized as 
Non-White. There were 8,821 inpatients carrying depression diagnoses and 2,967 patients 
carrying anxiety diagnoses. Expressing moderate to extreme suicidality, there were 12,126 
individuals. A complete list of variables that we assessed is included below in Table 2A.  
 
 
Table 2A. Univariate Analysis (n = 20,823) 
At admission 
Potential Confounders  N % 
Demographics gender female  10,767 51.7 
male  10,056 48.3 
race/ethnicity White 
13,020 
62.5 
Black, Asian, Native American Indian, 
Hispanic, Other 
7,803 
37.5 
 
age (years) 
Mean SD Range 
43.0 17.5 18-102 
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Key Variables N % 
Anxiety (Includes PTSD, SAD, GAD, OCD, 
and PD) 
 2,967 14.2 
 PTSD 1,866 9.0 
anxiety disorder not PTSD 1,218 5.8 
Depression  
(Includes MDD, mood disorder NOS, 
dysthymic disorder, or depressive disorder 
NOS) 
 8,821 42.4 
 major depressive disorder 7,252 34.8 
dysthymic disorder 163 0.8 
depressive disorder NOS 1,328 6.4 
mood disorder NOS 146 0.7 
Suicidality  greater than (but not 
including) little 
12,126 58.2 
Potential Confounders N % 
Diagnoses bipolar (BP) disorder 3,137 15.1 
substance use disorder 10,134 48.7 
Schizophrenia 2,565 12.3 
schizoaffective disorder 3,103 14.9 
other psychotic disorder 827 4.0 
eating disorder 340 1.6 
adjustment disorder 284 1.4 
impulse control disorder 351 1.7 
oppositional defiant disorder 5 0.0 
attention deficit disorder 202 1.0 
Paraphilia 34 0.2 
conduct disorder NOS 28 0.1 
Delirium 97 0.5 
personality change d/t medical condition 14 0.1 
pervasive developmental disorder 32 0.2 
Dementia 1,669 8.0 
cognitive disorder NOS 83 0.4 
personality disorder (any) 6,862 33.0 
borderline personality disorder 2,284 11.0 
 Mean SD Range 
Number of psychiatric diagnoses 2.0 1.4  0 - 10 
  N % 
Medications antidepressant anytime 14,901 71.6 
SSRI anytime 9,909 47.6 
TCA (tricyclics) anytime 672 3.2 
MAOI anytime 24 0.1 
other antidepressant anytime 8,622 41.4 
antipsychotic anytime 14,497 72.0 
anticonvulsant anytime 
(mood stabilizers) 
8,060 38.7 
lithium anytime 1,643 7.9 
stimulant anytime 140 0.7 
benzodiazepine anytime 7,962 38.2 
polypharm anytime 2,171 10.4 
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Univariate analyses for the 1 month and 6 month data subsets were then examined (Tables 
2B and 2C). Although anxiety and depression symptom information was not available at 
admission, symptom information was collected at the 1 month and 6 month follow-ups. 
 
 
 
Bivariate Crude Analyses 
By utilizing bivariate analysis, crude odds ratios (ORs) were determined in order to 
evaluate any possible associations between variables that suggest these variables might 
confound the anxiety diagnosis-suicidality or the depression diagnosis-suicidality 
association. A diagnosis of anxiety or depression was associated with an increased risk of 
having both anxiety and depression (OR = 3.13; CI = 2.88, 3.39). Furthermore, when looking 
Potential Confounders N % 
ECT  975 4.7 
Symptoms Difficulty managing day-to-day life (greater than 
moderate) 
18,232 87.6 
Difficulty managing day-to-day life (greater than little) 20,790 99.8 
Length of stay 
(days) 
 
Mean SD Range 
7.0 10.0 1-224 
Table 2B. Univariate Analysis (n = 948)  
At one month follow-up 
Key variables Variables 
n % 
Symptoms 
 
anxiety symptoms (fear, anxiety or panic) 432 44.8 
depressive symptoms (depression, hopelessness) 496 51.5 
suicidal feelings or behaviors (moderate to extreme) 215 22.7 
difficulty managing day to day 326 33.7 
Table 2C. Univariate Analysis (n = 202) 
At six month follow-up 
Key variables Variables 
n  % 
Symptoms anxiety symptoms (fear, anxiety or panic) 81 39.3 
depressive symptoms (depression, hopelessness) 99 47.8 
suicidal feelings or behaviors (moderate to extreme) 45 22.3 
difficulty managing day to day 55 26.6 
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at the crude analysis, depression was associated with an increased risk for suicidality (OR = 
3.53; CI = 3.33, 3.75) and anxiety was associated with an increased risk for suicidality (OR = 
2.80; CI = 2.56, 3.07). Impulse control disorder, oppositional defiant disorder, and paraphelia 
were not associated with anxiety, depression or suicidality. Numerous diagnoses were 
associated with risk for suicidality as shown below in Table 3A.  
Male gender was associated with a lower risk of having anxiety and depression (OR = 
0.39; CI = 0.36, 0.43 and OR = 0.56; CI = 0.53, 0.59 respectively), and was associated with a 
slightly lower risk for suicidality (OR = 0.91; CI = 0.86, 0.97). Being Non-White was 
associated with a decrease in the odds of having anxiety and depression but an increase in the 
risk for suicidality. Also, antidepressants, including selective serotonin reuptake inhibitors 
(SSRIs), stimulants, and polypharmacology (in this case, the use of more than one 
psychopharmacological agent) were associated with an increase in risk for suicidality. 
Lithium and antipsychotics were the only medications associated with a decreased risk for 
suicidality from the crude analysis. Difficulty managing day-to-day life, both greater than a 
little and greater than moderate, was associated with a significant elevation in the odds ratio 
for suicidality (greater than a little OR = 3.16; CI =2.89, 3.44; greater than moderate OR = 
9.04; CI = 7.33, 11.15).  
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Table 3A. Bivariate Analysis At Admission 
(n = 20,823) 
OR = odds ratio                                                                                                                                               Suggests decreased risk of suicdality 
CI = confidence interval, 95%                                                                                                                         Suggests increased risk of suicidality 
  
 
 
Anxiety Diagnoses 
(n1 = 2,967) 
Depression  
(n2 = 8,821) 
(Includes MDD, mood disorder 
NOS, dysthymic disorder, or 
depressive disorder NOS) 
Suicidality 
(n3 = 12,126) 
(greater than little) 
 Variable % of n1 OR CI % of n2 OR CI % of n3 OR CI 
D
em
o
g
ra
p
h
ics 
Gender: male 29.46 0.39 0.36, 0.43 40.02 0.56 0.53, 0.59 47.34 0.91 0.86, .97 
Race: Other  
     (Black, Asian, Native 
American Indian, 
Hispanic, Other) 
32.82 0.79 0.73, 0.86 36.40 0.92 0.87, 0.98 40.63 1.39 1.31, 1.47 
  Yes No  Yes No  Yes No 
Age  40.19 46.01  44.45 45.71  40.67 51.46 
  t = 16.91, p < 0.05  t = 5.17, p < 0.05  t= 46.14, p < 0.05 
K
ey
 
V
a
ria
b
les 
Anxiety XXXX XXXX XXXX 22.23 3.13 2.88 , 3.39  18.94 2.80 2.56, 3.07 
Depression  
    (Includes MDD, mood 
disorder NOS, dysthymic 
disorder, or depressive 
disorder NOS) 
66.09 3.13  2.88, 3.39  XXXX XXX XXXX 54.55 3.53 3.33, 3.75 
S
ym
p
to
m
s 
Difficulty managing day-
to-day life (greater than 
moderate) 
90.76 1.44 1.27, 1.65 87.56 1.00 0.92, 1.09 92.77 3.16 2.89, 3.44 
Difficulty managing day-
to-day life (greater than 
little) 
97.60 1.58 1.23, 2.02 96.12 0.90 0.77, 1.04 99.04 9.04 7.33, 11.15 
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   Anxiety Diagnoses  Depression Diagnoses  Suicidality 
D
ia
g
n
o
ses 
Variable % of n1 OR CI % of n2 OR CI % of n3 OR CI 
Dementia 1.35 0.14 0.10, 0.19 3.78 0.31 0.28, 0.35 2.44 0.13 0.12, 0.15 
Schizophrenia 2.53 0.16 0.13, 0.20 0.49 0.02 0.01, 0.03 6.70 0.28 0.26, 0.31 
Schizoaffective 9.44 0.56 0.49, 0.63 1.07 0.03 0.03, 0.04 14.12 0.86 0.80, 0.93 
Major depressive disorder 60.47 3.46 3.19, 3.75 82.21 N/A N/A 45.56 3.37 3.17, 3.60 
Other psychotic disorder 1.42 0.31 0.23, 0.43 1.45 0.24 0.20, 0.29 2.64 0.44 0.38, 0.51 
PTSD 62.89 N/A N/A 13.50 2.62 2.37, 2.89 12.63 3.61 3.19, 4.07 
Anxiety disorder not PTSD 41.05 N/A N/A 9.64 3.37 2.97, 3.82 7.03 1.73 1.52, 1.96 
Substance use disorder 48.50 0.99 0.92, 1.07 50.11 1.11 1.05, 1.17 56.39 2.12 2.00, 2.24 
Eating disorder 3.71 2.95 2.34, 3.72 2.68 3.15 2.49, 3.97 2.19 2.57 1.99, 3.32 
Adjustment disorder 0.91 0.63 0.42, 0.94 1.00 0.61 0.47, 0.78 1.68 1.84 1.42, 2.39 
Attention deficit disorder 1.79 2.16 1.58, 2.96 1.13 1.34 1.01, 1.77 1.12 1.48 1.10, 1.99 
Bipolar disorder 15.00 0.99 0.89, 1.11 0.67 0.02 0.02, 0.03 15.11 1.01 0.93, 1.09 
Conduct disorder 0.00 N/A N/A 0.02 0.10 0.03, 0.44 0.03 0.12 0.04, 0.34 
Delirium 0.17 0.33 0.13, 0.80 0.40 0.77 0.51, 1.16 0.22 0.28 0.18, 0.43 
Pervasive developmental 
disorder 
0.27 2.01 0.90, 4.48 0.11 0.62 0.29, 1.31 0.08 0.33 0.15, 0.69 
Cognitive disorder NOS 0.27 0.64 0.31, 1.33 0.57 2.07 1.33, 3.21 0.35 0.77 0.50, 1.19 
Personality disorder 53.05 2.69 2.48, 2.91 41.06 1.88 1.78, 2.00 43.54 3.47 3.25, 3.70 
Borderline Personality 
disorder 
27.00 4.08 3.71, 4.50 14.37 1.82 1.66, 1.98 15.99 4.61 4.10, 5.19 
M
ed
ica
tio
n
s 
Antipsychotic anytime 69.87 0.89 0.81, 0.96 56.15 0.25 0.23, 0.27 68.12 0.62 0.58, 0.66 
Antidepressant anytime 90.63 4.47 3.94, 5.08 94.38 13.85 12.56, 15.27 83.37 4.09 3.84, 4.36 
SSRI anytime 62.89 2.07 1.91, 2.24 67.03 4.07 3.84, 4.32 56.92 2.50 2.36, 2.65 
Anticonvulsant anytime 41.15 1.13 1.04, 1.22 25.46 0.36 0.34, 0.39 38.28 0.96 0.91, 1.01 
Lithium 6.07 0.72 0.62, 0.85 2.22 0.17 0.14, 0.19 7.22 0.81 0.73, 0.89 
Benzodiazepine anytime 50.29 1.78 1.65, 1.93 39.69 1.11 1.05, 1.18 37.29 0.91 0.86, 0.96 
Polypharm anytime 14.80 1.62 1.44, 1.81 7.38 0.55 0.50, 0.61 12.10 1.56 1.42, 1.72 
Stimulant anytime 0.71 1.06 0.67, 1.69 1.10 3.09 2.16, 4.43 0.83 1.87 1.29, 2.70 
E
C
T
 
ECT 5.29 1.17 0.98, 1.39 7.63 3.20 2.79, 3.68 4.64 0.98 0.86, 1.11 
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We then turned to bivariate analyses comparing admission data with 1 month and 6 
month data. Whereas the anxiety diagnoses examined in crude bivariate analysis at follow-up 
were associated with a decrease in suicidality, anxiety symptoms were associated with an 
increased risk of suicidality at 1 month post-discharge (OR = 8.30, CI = 5.70, 12.09) and at 6 
months post-discharge (OR = 18.69, CI = 7.36, 45.45). Additional crude analyses for 
depression symptoms and difficulty managing from day-to-day at 1 month and 6 month 
follow-up are described in Table 3C and 3D.  
 
Table 3B. Subsample: Bivariate at Admission For Comparison (n = 2,040) 
 Anxiety Diagnoses (n1=276) Depressive Diagnoses  
(any except bipolar) (n2=869) 
Suicidality (n3=942) 
(moderate to extreme) 
Variable % of 
n1 
OR CI % of 
n2 
OR CI % of 
n3 
OR CI 
Anxiety 
Diagnoses 
XX XX XXXX 21.63 3.40 2.59, 4.45 13.69 .93 0.68, 1.28 
Depressive 
Diagnoses 
68.12 3.40 2.59, 4.45 XX XX XXXX 44.06 1.10 0.88, 1.37 
Difficulty 
Managing 
Day to Day 
68.48 0.97 0.47, 2.00 67.78 1.17 0.70, 1.96 99.04 13.08 6.39, 26.77 
          
          
Table 3C. Bivariate at 1 Month Follow-up (n = 948)  
 Anxiety Symptoms (n1=432) 
(fear, anxiety or panic) 
Depressive Symptoms 
(n2=496) 
(depression, hopelessness) 
Suicidality (n3=215) 
Suicidal feelings or behaviors                                               
(moderate to extreme) 
Variable % of 
n1 
OR CI % of 
n2 
OR CI % of 
n3 
OR CI 
Anxiety 
Symptoms 
XX XX XXXX 70.56 11.78 8.64, 16.05 80.93 8.30 5.70, 12.09 
Depressive 
Symptoms 
81.02 11.78 8.64, 16.05  XX XX XXXX 92.56 26.29 14.41,47.96 
Difficulty 
Managing 
Day to Day 
56.71 7.60 5.59, 10.33 53.63 8.22 5.93, 11.41 66.05 6.00 4.32, 8.34 
Anxiety 
Diagnoses 
11.11 0.87 0.59, 1.29 12.10 1.06 0.71, 1.56 10.70 0.89 0.54, 1.43 
Depressive 
Diagnoses  
(any except 
bipolar) 
45.60 1.09 0.85, 1.41 46.37 1.21 0.94, 1.56 46.05 1.10 0.81, 1.50 
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Table 3D. Bivariate at 6 Month Follow-up (n=202) 
 Anxiety Symptoms  
(n1=81) 
(fear, anxiety or panic) 
Depressive Symptoms 
(n2=99) 
(depression, hopelessness) 
Suicidality  
(n3=45) 
Suicidal feelings or behaviors                                               
(moderate to extreme) 
Variable % of 
n1 
OR CI % of 
n2 
OR CI % of 
n3 
OR CI 
Anxiety 
Symptoms 
XX XX XXXX 73.74 36.50 15.58, 85.52 86.67 18.69 7.36, 47.45 
Depressive 
Symptoms 
90.12 36.50 15.58, 85.52 XX XX XXXX 97.78 88.00 11.79, 656.69 
Difficulty 
Managing 
Day to Day 
55.56 16.57 7.38, 37.23 47.47 13.30 5.61, 31.50 64.44 9.06 4.32, 19.02 
Anxiety 
Diagnoses 
14.81 1.11 0.50, 2.46 18.18 1.96 0.88, 4.39 11.11 0.77 0.27, 2.16 
Depressive 
Diagnoses  
(any except 
bipolar) 
51.85 1.29 0.73, 2.25 51.52 1.33 0.77, 2.30 53.33 1.35 0.69, 2.62 
 
Stratified analysis was then used to assess for evidence that demographics, diagnoses, 
or pharmacological agents confounded the anxiety diagnosis - suicidality association. These 
analyses suggest that antidepressant use and having greater than little difficulty (includes 
“moderate,” “quite a bit,” or “extreme”) managing day-do-day variables confound but do not 
modify the anxiety diagnosis – suicidality association. We found no evidence that the 
variables examined confounded the depression diagnosis – suicidality association.  
Two-way interactions were then used to assess for synergism and antagonism. As 
described in the Methods section, if we found that excess risk in the doubly exposed category 
was greater than the sum of the two singly exposed categories by a margin of ± 25%, 
synergism was suspected. 
Analysis of anxiety and depression diagnoses provided no evidence of synergism in 
the risk of suicidality. Evidence of synergism was found between an anxiety diagnosis and,  
 gender  
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 difficulty managing day-to-day greater than a little  
 difficulty managing day-to-day greater than moderate 
 antipsychotics 
 antidepressants (not the subcategory of SSRI’s)  
 polypharmacological agents 
 stimulants 
 borderline personality disorder. 
A depression diagnosis and the following variables met our criterion for synergism,  
 difficulty managing from day-to-day greater than a little  
 difficulty managing from day-to-day greater than moderate 
  substance use disorder 
 antidepressants (slight) 
 lithium 
If the doubly exposed category was less than the sum of the two singly exposed by a 
margin of ± 25%, antagonism was suspected. The only variable that appeared to act 
antagonistically on the effect of anxiety (diagnoses) on suicidality was eating disorder. 
Variables that appeared to act antagonisitcally on the effect of depression (diagnoses) on 
suicidality included race, benzodiazepines, and ECT. 
Through analysis of two-way interactions at 1 month, findings suggested that anxiety 
symptoms and depressive symptoms acted synergistically to increase the risk of suicidality 
(see Table 4 below). Evaluating two-way interactions at 6 month was not possible due to 
devisors of 0 in the denominators. 
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Table 4. Example of assessing interaction on an additive scale for two dichotomous 
exposures and a dichotomous outcome 
 
ONE MONTH FOLLOW-UP 
 Exposure 1   Non-exposure 1 
 Exposure 2 Non-exposure 2   Exposure 2 Non-exposure 2 
Cases 163 35  Cases 9 3 
Non-Cases 180 101  Non-cases 70 374 
Total 343 136   79 377 
 
Exposure 1= Difficulty with depression, hopelessness at 1 month follow-up 
Exposure 2 = Difficulty with fear, anxiety, panic at 1 month follow-up 
Cases = Difficulty with suicidal feelings or behaviors at 1 month follow-up  
 
Additivity criteria => If  the equality holds, no interaction  
 
 
 
      112.89      ≠  58.23   => Interaction or synergism as equality does not hold by a margin > 25% 
 
 
Binary Logistic Regression  
The next analysis we performed was binary logistic regression (results shown in 
Table 5). The model fit was assessed for the regression model of risk of suicidality at 
admission, and the Nagelkerke R Square was 0.35. Variables that were forced into the 
equation included anxiety, depression, age, race, and gender. The remainder of the variables 
were entered as covariates and selected for retention in the model by forward stepwise 
conditional method. Anxiety diagnoses was associated with an increased risk for suicidality. 
After controlling for demographics, diagnoses and medications, the OR for anxiety diagnosis 
was 1.38 (CI = 1.24, 1.35) indicating that an anxiety diagnosis was statistically significantly 
associated with a 38% increased risk of suicidality. Many mental illnesses including axis II 
diagnoses were associated with an increase in suicidality including schizoaffective, 
borderline personality disorder, substance abuse disorder, adjustment disorder, and bipolar 
disorder. Certain diagnoses such as schizophrenia decreased the risk for suicidality (OR = 
( ) ( ) ( )
1
( ) ( ) ( )
R AB R AB R AB
R AB R AB R AB
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0.60 , CI = 0.53, 0.68). Some medications decreased the risk for suicidality while 
antidepressants, for example, increased the odds ratio for sucidality. Again, difficulty 
managing day-to-day significantly increased suicidal risk more than 7 fold (OR = 7.86, 6.24, 
9.90). The following variables were eliminated during stepwise regression: eating disorder, 
impulse control disorder, oppositional defiant disorder, paraphilia, conduct disorder, 
delirium, personality change due to a medical condition, antipsychotic (any), anticonvulsant 
(any), stimulant (any), and ECT.  
In subanalyses, we then analyzed suicidality at 1 and 6 month follow-ups, forcing the 
variables that were maintained in the above model into a new binary logistic regression 
analysis. The results were not statistically significant as demonstrated in Table 5. In these 
analyses, for some variables scant data resulted in variables included in the cross-sectional 
analysis being dropped. 
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Table 5. Regression Analyses: Variables Remaining In the Equation, OR and 95% CI 
 
At admission 
(n = 20,823; missing 55across 
various data points) 
At one month follow-up 
n = 530 
At six month follow-up 
n = 115 
 
 OR CI OR CI OR CI 
Anxiety 1.38 1.24, 1.53 0.89 0.46, 1.74 0.42 0.09, 1.88 
Depression 2.64 2.38, 2.94 0.88 0.43, 1.76 0.98 0.22, 4.27 
Gender  (Males) 1.25 1.17, 1.35 0.86 0.54, 1.38 0.46 0.15, 1.37 
Race  (Non-White) 1.35 1.26, 1.46 1.02 0.64, 1.63 0.92 0.32, 2.66 
Age 0.97 0.97, 0.98 1.01 0.99, 1.03 1.02 0.98, 1.06 
Dementia 0.49 0.42, 0.57 1.01 0.38, 2.67 0.17 0.01, 3.52 
Schizophrenia 0.60 0.53, 0.68 0.71 0.30, 1.67 0.22 0.02, 2.19 
Schizoaffective 1.24 1.10, 1.40 0.99 0.44, 2.27 0.46 0.06, 3.36 
Other psychotic disorder 0.67 0.56, 0.80 0.75 0.19, 2.93 0.33 0.02, 4.99 
Substance use disorder 1.42 1.32, 1.53 1.21 0.73, 2.00 0.73 0.23, 2.30 
Adjustment disorder 1.85 1.38, 2.48 1.40 0.26, 7.62 0.62 0.05, 8.06 
Attention deficit disorder 0.67 0.48, 0.92 4.05 0.51, 32.01 N/A N/A 
Bipolar disorder 1.53 1.35, 1.73 0.73 0.32, 1.69 0.42 0.07, 2.62 
Pervasive developmental disorder 0.18 0.08, 0.39 0.00 N/A N/A N/A 
Borderline Personality disorder 2.78 2.43, 3.18 1.33 0.65, 2.71 2.37 0.49,11.62 
Antidepressants (any) 2.97 2.75, 3.22 1.35 0.80, 2.29 0.96 0.23, 3.98 
Lithium (any) 0.90 0.79, 1.01 1.02 0.43, 2.42 0.60 0.31, 2.42 
Benzodiazepine (any) 0.85 0.79, 0.91 0.71 0.45, 1.10 0.87 0.31, 2.42 
Difficulty managing day-to-day greater than a little 7.86 6.24, 9.90 0.87 0.31, 2.46 0.00 N/A 
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CHAPTER V 
DISCUSSION 
Our study found that, in a sample of adult psychiatric hospitalized inpatients, anxiety 
and depression diagnoses were associated with approximately 40% and 160% increased risk 
of suicidality, after controlling for demographic and clinical confounders. Furthermore, our 
analysis provided evidence that the effects on risk of suicidality of these two diagnostic 
groups were independent, neither synergistic nor antagonistic. However, our analysis 
provided evidence that many other personal and clinical factors did interact with either 
anxiety or depression diagnosis to modify these diagnoses’ association with suicidality. 
We have already established that the role of anxiety in suicidality is complicated. In 
the passage below, noted author William Styron provides a glimpse at the damaging effects 
of anxiety: 
But it is my conviction now that alcohol played a perverse trick on me when 
we said farewell to each other: although, as everyone should know, it is a 
major depressant, it had never truly depressed me during my drinking career, 
acting instead as a shield against anxiety. Suddenly vanished, the great ally 
which for so long had kept my demons at bay was no longer there to prevent 
those demons from beginning to swarm through the subconscious, and I was 
emotionally naked, vulnerable as I had never been before. (Styron, 1990, p. 
43).  
In William Styron’s memoir, Darkness Visible, he described how anxiety played a significant 
role in the progression and development of his depression, resulting in suicidal ideation. In 
fact, Styron believed alcoholism is what dampened his anxiety and staved off his depression. 
Despite such vivid accounts detailing how anxiety can prompt suicidality, there is still much 
disagreement about the anxiety – suicidality association. For example, one study not only 
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suggested that comorbid panic disorder and depression in psychiatric inpatients (each patient 
had at least one major depressive episode with or without a suicide attempt history) did not 
increase lifetime suicide attempts but instead that higher levels of anxiety and agitation 
offered protection against suicidality in the target population of 272 patients (Placidi et al., 
2000). However, as already described in the results, our study within the inpatient adult 
population demonstrated that anxiety was statistically significantly associated with 
suicidality after controlling for confounders including other psychiatric diagnoses (such as 
depression). Even though our research did not delineate ideation from attempts or completed 
suicide, our results suggest that clinicians need to be aware of the significant role that anxiety 
may play in the development of suicidal behaviors. This conclusion is reinforced by the 
WHO’s cross-national analysis, examining the association of mental disorders and suicidal 
behavior, which suggested that clinicians should be mindful that anxiety may be an important 
risk factor influencing whether a patient transitions from suicidal thoughts to attempts or 
even to completed suicide (Nock et al., 2009). Although we did not find synergism or 
antagonism when an anxiety diagnosis was coupled with a unipolar depression diagnosis, 
both diagnoses were statistically significantly associated with increased suicidality, providing 
evidence that an anxiety disorder should be considered a risk factor, independent of 
depression, for suicidal behaviors.   
Further suggesting an association between anxiety and suicidality, benzodiazepines 
which are used in the treatment of anxiety disorders, were associated with a reduced risk of 
suicidality in both the bivariate and regression analyses. Therefore, the administration of 
benzodiazepines in a patient who presents with an anxiety diagnosis could potentially be 
therapeutic in preventing suicidal behaviors. Antipsychotics, anticonvulsants, and stimulants 
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were not retained for inclusion in the regression model, indicating that these 
psychopharmacological agents were not statistically significantly associated with suicidality 
after controlling for other factors’ effects. However, antidepressants were associated with 
increased risk of suicidality, suggesting that care should be taken when administering this 
medication and that patients should be carefully monitored for signs of developing 
suicidality. In fact, one commonly listed side effect of certain antidepressants is anxiety 
(Mayo Foundation for Education and Research, 2008) which perhaps may account for the 
increased suicidal risk found in our sample, despite these medications’ presumed alleviation 
of depressive symptoms. Joiner (2010) described that antidepressants might be “activating” 
and that too much activation might result in anxiety, agitation, and restlessness, which he 
notes as indicators for high risk of suicidality. In this author’s (MT) personal communication 
with T. Joiner, he remarked: 
I often say in trainings “I've never heard anyone about to die or almost die by 
suicide described as sluggish... agitated, on edge, can't sleep, hyped up, 
nervous energy, yes - but never sluggish.” This state is key to understanding 
suicidal behavior, and it is underappreciated. (March 14, 2010) 
 
Fawcett (Jancin, 2003) made similar references regarding suicidality at the Annual 
Conference of the American Association of Suicidology (Santa Fe, 2003). Fawcett even 
indicated that it was his professional goal to have the severity of a patient’s anxiety assessed 
as part of routine clinical suicidal assessments. In a study, Busch and Fawcett (2003) 
examined the suicide risk of inpatients. Chart reviews were completed on 76 patients 
between the ages of 15-76 who committed suicide while they were in inpatient treatment. 
Items from the Schedule for Affective Disorders and Schizophrenia (SADS) and traditional 
risk factors (including previous suicide attempt and suicidal ideation) had been evaluated 
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during the week before the patient committed suicide. Surprisingly, 78% denied any suicidal 
ideation during their “last communication” and the researchers concluded that the standard 
risk predictors were in fact “not predictive” for acute risk (Busch & Fawcett, 2003). 
However, in the last week of their lives, 79% of inpatients had met the SADS criteria for 
severe anxiety or agitation. This raises the point that suicide assessments that only focus on 
questions regarding ideation, intent, plan and lethality of method may have limited utility as 
predictors of completed suicides. Furthermore, due to the tremendous stigma of suicide 
(Joiner, 2005), people may feel reluctant to admit suicidality; however, one could surmise 
that patients would more readily admit to severe anxiety (as the above study suggests) giving 
credence to Fawcett’s professional goal. 
Obviously not everyone with symptoms of anxiousness meets criteria for a DSM-IV-
TR (2000) anxiety diagnosis. Logically, because our research indicated that an anxiety 
diagnosis was associated with increased suicidality (after controlling for numerous 
covariates), the next step was to discern if the presence of the symptoms of anxiety (without 
an anxiety diagnosis or by controlling for various anxiety diagnoses) was predictive of 
suicidality. In our preliminary analysis of the presence versus absence of anxiety symptoms 
in adult inpatients (who did not necessarily have an anxiety diagnosis) at 1 month post 
discharge, the presence of anxiety symptoms was associated with an 8-fold increased suicidal 
risk. One possible explanation is that anxiety may in fact be one of the underlying 
commonalities across mental illnesses that accounts for the risk of suicidality. One could 
argue that the presence of mental illness, and perhaps any type of illness that is not 
completely curable, is indeed anxiety provoking. Although our findings were not conclusive 
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of this point, these preliminary data suggest that an analysis of symptoms or symptom 
clusters may better predict suicidal risk than a DSM-IV diagnosis.  
For example, in this study difficulty managing from day-to-day (greater than a little), 
an indicator of stress that might be expected to increase anxiety, was strongly associated with 
a 7-fold increased risk for suicidality. However, The Columbia Suicide Severity Rating Scale, 
(Posner et al., 2008) and The Reasons for Living Inventory (Linehan, Goodstein, Nielsen, & 
Chiles, 1983) do not directly assess client anxiety or difficulty managing from day-to-day. 
Nonetheless, our data suggest that instruments such as these might be complemented by 
asking about anxiety and difficulty managing from day-to-day and that asking these clinical 
questions may be important because suicidal patients may be reluctant to admit they are at 
risk (Busch & Fawcett, 2003).   
In addition, when analyzing two-way interactions in a preliminary analysis, we found 
that the risks associated with anxiety symptoms and depression symptoms were synergistic; 
i.e., the risk in patients having both symptoms exceeded the risk expected from the additive 
effects of suicide risk due to depression symptoms alone plus suicide risk due to anxiety 
symptoms alone. Further research is warranted to examine the effects of symptom clusters on 
suicidal risk. Intimating that there is not just one factor responsible for suicidality, in Joiner’s 
personal correspondence (personal communication, March 14, 2010) he indicated that 
depression, anxiety and numerous other factors exert influence on suicidality. However, 
Joiner stated that he believed that these biological, social, or environmental risk factors exert 
influence through a common pathway that ties together dozens of risk factors. The theoretical 
model that he proposes, which outlines his idea of the common pathway, is that suicidality 
occurs when there is a combination of learned fearlessness (“a type of habituation to suicidal 
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behaviors which impedes the fear and pain associated with self-harm”), and two 
simultaneously occurring long-term mind-states (Joiner, 2005, p. 59). The first mind state is 
perceived burdensomeness where a person perceives that he (she) is a burden and his (her) 
death is worth more than his (her) life to others. The second mind-which is termed failed 
belongingness is the person’s perception that he (she) is completely alienated from others 
(see Figure 1 below).  
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FIGURE 1. ADAPTED FROM JOINER:  WHY PEOPLE DIE BY SUICIDE 
 
LEARNED FEARLESSNESS Acquisition of the ability to enact lethal self-injury that 
causes one to become suicidal acquired through time and repetition. 
 
SUICIDE 
 
SUICIDAL 
BEHAVIORS 
Adapted with permission from T. Joiner, 
personal communication, May 14, 2010 
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The relevance of Joiner’s theory to the current study’s findings are that multiple 
factors might act in concert to overcome the will to live, indicating that more research about 
the effects of symptoms and symptom clusters is needed to assess the independent and 
combined roles they may play in the risk of suicidality, and the need to further qualify the 
nature of the anxiety. Additional analysis of anxiety and the risk of suicidality may indicate 
that the symptom of anxiety is truly part of the “common pathway” and not an ancillary 
contributing factor. In this case, anxiety associated with suicidality might be examined for 
evidence that it has specific qualities that produce so much discomfort that the patient 
inherently can no longer cope with the pain and needs an immediate change. Fawcett and 
Harris (2001) described it as a “ruminative form of anxiety,” eloquently stating “the constant 
repetition of this increasingly fearful idea becomes inescapable torture for the patient, true 
psychic pane, from which the idea that the only escape is death seems a logical conclusion” 
(p. 480). In an examination of Joiner’s theoretical model, one might ask what came first, the 
habituation/learned fearlessness to risk bodily harm or the ruminative anxiety about 
continuing to cope in the world? This author (MT) suggests that a person’s inability to 
tolerate this frenetic form of anxiety may be the common pathway to suicidality and that an 
acquired ability to enact lethal self-injury through time and repetition, although certainly a 
risk factor, is not necessarily part of “the common pathway.”   
If learned fearlessness was in fact the common pathway for completed suicide, one 
would potentially expect that with each additional trauma [as Joiner (2005) indicates that 
repetitive exposure to trauma could be a contributing factor to learning fearlessness] there 
would be an additive or supra-additive effect of each trauma increasing the risk for suicidal 
ideation and attempt. However, in a study recently conducted with data from the WHO 
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World Mental Health Surveys (Stein et al., 2010), findings suggested that although there was 
a dose-effect of an increase in suicidal ideation and attempt as the number of trauma 
exposures increases, there is a subadditive effect in the strength of the association with 
suicidal ideation and attempt. In other words, the magnitude of the effect of each additional 
trauma on suicidality, decreases with each exposure (Stein et al., 2010). Again, future 
research on anxiety symptoms in relationship to suicidality is warranted.   
Limitations 
Measurement errors may have occurred because data were obtained from clinical 
records and via patient self-reports, and because of retrospective reports and any limitations 
in scales. For example, when measuring suicidality (an ordinal variable) we cannot assume 
that the magnitude of the change in morbidity between “no” and “little” suicidality is equal to 
the magnitude between “quite a bit” and “extreme.” This limitation was addressed by 
dichotomizing suicidality while assuming the ordinal nature of the original Likert scale. For 
the substudy analysis, there is the possibility that selection bias was introduced if only certain 
categories of patients were willing to respond to the questionnaires mailed at 1 and 6 month 
follow-up.  
An additional limitation involves the lack of symptom (in contrast to diagnoses) 
information recorded at admission and discharge into the hospital database during the 
designated study period. As a result, we were unable to draw comparisons between 
admission and post-discharge anxiety symptoms, and thus we could not establish that 
independent variables preceded suicidality. Also, because the population consisted only of 
psychiatric inpatients, there is a question about generalizability to a broader clinical 
population or to the general population at-large. 
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Although there are limitations in this study, the potential benefit to clinical practice 
from a large study including examination of combinations of potential risk factors not 
thoroughly examined in previous research has merit. This study provides additional 
understanding about the associations of anxiety and depression with suicidality which has 
obvious important implications for patient safety. 
Conclusions 
In conclusion, we found that anxiety diagnoses were associated with increased 
suicidal risk when controlling for confounding in an inpatient adult population. As 
anticipated, depression diagnosis was also associated with suicidality, but this diagnosis did 
not explain the statistically significant association between anxiety diagnosis and suicidality. 
We did not find a synergistic effect on suicidality when comorbid anxiety and depression 
were present. Preliminary analyses suggest that anxiety symptom information may be a better 
predictor of suicidality than the presence of a DSM-IV diagnosis. Additional research is 
warranted to examine the nature of anxiety symptoms that precede suicidal behaviors and to 
examine if symptom clusters work synergistically to increase suicidal risk as well as what 
symptom clusters present the greatest suicidal risk. 
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